Korean J Hematol 1994; 29(2):

Published online June 30, 1994

© The Korean Society of Hematology

범발성혈관내응고증환자의 혈중 Tissue-Type Plasminogen Activator, Type 1 Plasminogen Activator Inhibitor 및 von Willebrand Factor변동에 관한 연구

정철원, 안진석, 박선양, 김병국, 김노경

서울대학교 의과대학 내과학교실

Changes of Tissue-Type Plasminogen Activator, Type 1 Plasminogen Activator Inhibitor, and von Willebrand Factor in Disseminated Intravascular Coagulation

Chul Won Jung, Jin Seok Ahn, Seonyang Park, Byoung Kook Kim, Noe Kyoung Kim

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

Abstract

Background : Anecdotal reports on the changes of tissue-type plasminogen activator(tPA), plasminogen activator inhibitor-1(PAI-1), von Willebrand factor(vWF) in
patients with disseminated intravascular coagulation(DIC) have not been constant. Development of DIC has been well documented in patients with hemorrhagic fever with
renal syndrome(HFRS), Tsutsugamushi disease, snake bite, acute promyelocytic leukemia. So we measured the levels of tPA, PAI-1 and vWF during different stages of DIC to elucidate the role of endothelial perturbation in the pathogenesis of those diseases.
Methods: Blood samples from 24 patients with DIC were collected daily during admission and once during convalescent period. tPA and PAI-1 were measured using
commercially available ELISA kits and vWF using rocket immunoelectrophoresis.
Results: tPA, PAI-1 and vWF in 9 serologically proven patients with HFRS had peaks during the 4-5th days of disease and decreased to normal since the 10th day of
disease. Ten Tsutsugamushi disease patients showed dual peaks during the first 14 days and the tPA peak preceded PAI-1 peak by 2-3 days. There had been only a slight
increase in tPA, PAI-1 and vWF in 2 patients with snake bite and 3 patients with acute promyelocytic leukemia.
Conclusion: In patients with HFRS and Tsutsugamushi disease plasma concentration of tPA, vWF and PAI-1 increased during developmental stage of DIC, and normalized
as DIC resolved.

Keywords DIC; Tissue-type plasminogen activator; Plasminogen activator inhibitor-1; von Willebrand factor;

Article

Korean J Hematol 1994; 29(2): 199-206

Published online June 30, 1994

Copyright © The Korean Society of Hematology.

범발성혈관내응고증환자의 혈중 Tissue-Type Plasminogen Activator, Type 1 Plasminogen Activator Inhibitor 및 von Willebrand Factor변동에 관한 연구

정철원, 안진석, 박선양, 김병국, 김노경

서울대학교 의과대학 내과학교실

Changes of Tissue-Type Plasminogen Activator, Type 1 Plasminogen Activator Inhibitor, and von Willebrand Factor in Disseminated Intravascular Coagulation

Chul Won Jung, Jin Seok Ahn, Seonyang Park, Byoung Kook Kim, Noe Kyoung Kim

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

Abstract

Background : Anecdotal reports on the changes of tissue-type plasminogen activator(tPA), plasminogen activator inhibitor-1(PAI-1), von Willebrand factor(vWF) in
patients with disseminated intravascular coagulation(DIC) have not been constant. Development of DIC has been well documented in patients with hemorrhagic fever with
renal syndrome(HFRS), Tsutsugamushi disease, snake bite, acute promyelocytic leukemia. So we measured the levels of tPA, PAI-1 and vWF during different stages of DIC to elucidate the role of endothelial perturbation in the pathogenesis of those diseases.
Methods: Blood samples from 24 patients with DIC were collected daily during admission and once during convalescent period. tPA and PAI-1 were measured using
commercially available ELISA kits and vWF using rocket immunoelectrophoresis.
Results: tPA, PAI-1 and vWF in 9 serologically proven patients with HFRS had peaks during the 4-5th days of disease and decreased to normal since the 10th day of
disease. Ten Tsutsugamushi disease patients showed dual peaks during the first 14 days and the tPA peak preceded PAI-1 peak by 2-3 days. There had been only a slight
increase in tPA, PAI-1 and vWF in 2 patients with snake bite and 3 patients with acute promyelocytic leukemia.
Conclusion: In patients with HFRS and Tsutsugamushi disease plasma concentration of tPA, vWF and PAI-1 increased during developmental stage of DIC, and normalized
as DIC resolved.

Keywords: DIC, Tissue-type plasminogen activator, Plasminogen activator inhibitor-1, von Willebrand factor,

Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download